navitoclax,regorafenib,ruxolitinib
abbvie,novartis,incyte,bayer
['regorafenib', 'refine study', 'hcc']
 asco is over! check out the abstract on regorafenib in pts with unresectable #hcc in real-world practice in the us confirmed safety &amp; effectiveness of #regorafenib in a broad population of pts read more on this final analysis of the #refine study 
COR2ED bringing you Independent Medical Education developed 
by HCC CONNECT, international experts in Liver oncology